Buccal Mucosa Bleeding Time Is Prolonged in Canine Models of Primary Hemostatic Disorders

Summary

Bleeding times are reported in many studies using canine models, with a variety of techniques employed to adapt these tests for dogs. We evaluated a canine model of template bleeding time, the buccal mucosa bleeding time (BMBT), by examining the test’s sensitivity and specificity for defects of primary hemostasis. We examined thirty-five dogs having defined defects of either primary hemostasis (Types I, II, III von Willebrand’s disease, thrombasthenia, thrombopathia) or secondary hemostasis (hemophilia A and B, Factor VII deficiency). Comparisons of BMBT and cuticle bleeding time were made in a subset of these dogs.

All dogs having primary hemostatic disorders had long BMBT, and all factor deficient dogs had BMBT within normal range. The BMBT in canine models appears to be a specific and sensitive test of primary hemostasis; suitable for evaluating factors affecting template bleeding time and potential efficacy and thrombogenicity of treatment regimens.

• References

• 1 Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972; 287: 155-159
• 2 Day HJ, Rao AK. Evaluation of platelet function. Semin Hematol 1986; 23: 89-101
• 3 Bowie EJW, Owen CA. Standardization of the bleeding time. Scand J Haematol 1980; 25: 87-94
• 4 Mielke CH. International Committee Communications: Measurements of the bleeding time. Thromb Haemostas 1984; 52: 210-211
• 5 Caekebeke-Peerlink MJ, Koster T, Briët E. Bleeding time, blood groups and von Willebrand factor. Br J Haematol 1989; 73: 217-220
• 6 Koster T, Caekebeke-Peerlink MJ, Briët E. A randomized and blinded comparison of the sensitivity and the reproducibility of the Ivy and Simplate II bleeding time techniques. Am J Clin Pathol 1989; 92: 315-320
• 7 Roper-Drewinko PR, Drewinko B, Corrigan G, Johnston D, McCredie KB, Freirich EJ. Standardization of platelet function tests. Am J Hematol 1981; 11: 183-203
• 8 Channing RodgersRP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 16: 1-20
• 9 Smith PS, Baglini R, Meissner GF. Prolonged bleeding time in hemophilia A: comparison of two measuring techniques and clinical associations. Am J Clin Pathol 1984; 83: 211-215
• 10 MacGregor IR, Ferguson JM, McLaughlin LF, Burnouf T, Prowse CV. Comparison of high purity factor IX concentrates and a prothrombin complex concentrate in a canine model of thrombogenicity. Thromb Haemostas 1991; 66: 609-613
• 11 Casali RE, Hale JA, LeNarz L, Faas F, Morris MD. Improved graft patency associated with altered platelet function induced by murine fatty acids in dogs. J Surg Res 1986; 40: 6-12
• 12 Garabedian HD, Gold HK, Leinbach RC, Svizzero TA, Finkelstein DM, Guerrero JL, Collen D. Bleeding time prolongation and bleeding during infusion of recombinant tissue-type plasminogen activator in dogs: potentiation by aspirin and reversal with aprotinin. J Am Coll Cardiol 1991; 17: 1213-1222
• 13 Dodds WJ. Third international registry of animal models of thrombosis and hemorrhagic diseases. ILAR News 1988; 30: Rl-32
• 14 Thomas R, Hessel EA, Dillard DH, Harker LA. Standardized template bleeding time in dogs. J Surg Res 1979; 27: 244-249
• 15 Dodds WJ. Joint report of the subcommittees on animal models of hemorrhagic and thrombotic diseases and on platelets. Thromb Haemostas 1982; 48: 106-107
• 16 Forsythe LT, Willis SE. Evaluating oral mucosa bleeding times in healthy dogs using a spring loaded device. Can Vet J 1989; 30: 344-345
• 17 Brassard JA, Meyers KM. Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency. Thromb Haemostas 1991; 65: 191-195
• 18 Chabbat J, Hampikian-Lenin S, Toully V, Gaillandre A, Pejaudier L, Steinbuch M. A human factor Vila concentrate and its effect in the hemophilic dog. Thromb Res 1989; 54: 603-612
• 19 Kingdon HS, Hassell TM. Hemophilic dog model for evaluating therapeutic effectiveness of plasma protein fractions. Blood 1981; 58: 868-872
• 20 Giles AR, Tinlin S, Greenwood R. A canine model of hemophilic (factor VIII :C deficiency) bleeding. Blood 1982; 60: 727-730
• 21 Jergens AE, Turrentine MA, Kraus KH, Johnson GS. Buccal mucosa bleeding times of healthy dogs and of dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand’s disease. Am J Vet Res 1987; 48: 1337-42
• 22 Dodds WJ. Bleeding disorders. In: Clinical biochemistry of domestic animals. Kaneko JJ. (ed) San Diego: Academic Press; 1989: 274-315
• 23 Catalfamo JL, Raymond SL, White JG, Dodds WJ. Defective platelet-fibrinogen interaction in hereditary canine thrombopathia. Blood 1986; 67: 1568-1577
• 24 Dodds WJ. Familial canine thrombocytopathy. Thromb Diath Haemorrh 1967; 26: 241-248
• 25 Giles AR. Guidelines for the use of animals in biomedical research. Thromb Haemostas 1987; 58: 1078-1084
• 26 Benson RE, Catalfamo JL, Brooks M, Dodds WJ. A sensitive immunoassay for von Willebrand factor. J Immunoassay 1991; 12: 371-390
• 27 Brosstad F, Kjonniksen I, Ronning B. Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies. Thromb Haemostas 1986; 55: 276-278
• 28 Pijnappels MI, Briët E, van derZwet GT, Huisden R, van TilburgNH, Eulderink F. Evaluation of the cuticle bleeding time in canine haemophilia A. Thromb Haemostas 1986; 55: 70-73
• 29 VanderVelden P, Giles AR. A detailed morphological evaluation of the evolution of the haemostatic plug in normal, factor VII and factor VIII deficient dogs. Br J Haematol 1988; 70: 345-355
• 30 Giles AR, Tinlin S, Brosseau L. In vivo studies of the role of factor VII in hemostasis. Blood 1985; 65: 1197-1200
• 31 Giles AR, Tinlin S, Hoogendoorn H, Fournel MA, Ng P, Pancham N. In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency). Blood 1988; 72: 335-339
• 32 Brinkhous KM, Hedner U, Garris JB, Diness V, Read MS. Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease. Proc Natl Acad Sci 1989; 86: 1382-1386